Patents by Inventor J. David Lambeth
J. David Lambeth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7524936Abstract: The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: February 27, 2007Date of Patent: April 28, 2009Assignee: Emory UniversityInventors: J. David Lambeth, Guangjie Chang
-
Patent number: 7247709Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: March 15, 2006Date of Patent: July 24, 2007Assignee: Emory UniversityInventors: J. David Lambeth, Kathy K. Griendling, Bernard P. Lassegue, Rebecca S. Arnold, Guangjie Cheng
-
Patent number: 7244590Abstract: The present invention relates to nucleotides encoding for the production of novel regulatory proteins for Nox enzymes involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these nucleotides, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these nucleotides and proteins, and methods to determine the activity of drugs to affect the biological activity of the regulatory proteins of the present invention.Type: GrantFiled: September 14, 2005Date of Patent: July 17, 2007Assignee: Emory UniversityInventors: J. David Lambeth, Guangjie Cheng
-
Patent number: 7226769Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates and in peroxidative reactions that affect biological functions including cell division, thyroid hormone biosynthesis and tissue fibrosis. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: May 14, 2001Date of Patent: June 5, 2007Assignee: Emory UniversityInventors: J. David Lambeth, Bernard P. Lassegue, Kathy K. Griendling, Rebecca S. Arnold, Guangjie Cheng, Lisa Sharling, Guy Benian, William A. Edens
-
Patent number: 7202053Abstract: The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: May 20, 2004Date of Patent: April 10, 2007Assignee: Emory UniversityInventors: J. David Lambeth, Guangjie Cheng
-
Patent number: 7202052Abstract: The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: May 20, 2004Date of Patent: April 10, 2007Assignee: Emory UniversityInventors: J. David Lambeth, Guangjie Cheng
-
Patent number: 7119249Abstract: The present invention provides a transgenic non-human animal, in particular a transgenic mouse encoding the NOX and Duox family of proteins, which generate reactive oxygen intermediates (ROI). The present invention additionally comprises cells and cell lines containing transgenes encoding for members of the NOX and Duox family of proteins. The present invention further comprises methods and compositions for evaluating regulators of abnormal cell growth and in the development of compounds that effect ROI expression.Type: GrantFiled: July 14, 2003Date of Patent: October 10, 2006Assignee: Emory UniversityInventors: J. David Lambeth, Guangjie Cheng, James McCoy
-
Patent number: 7048923Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: December 13, 2002Date of Patent: May 23, 2006Assignee: Emory UniversityInventors: J. David Lambeth, Kathy K. Griendling, Bernard P. Lassegue, Rebecca S. Arnold, Guangjie Cheng
-
Patent number: 7045351Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: December 13, 2002Date of Patent: May 16, 2006Assignee: Emory UniversityInventors: J. David Lambeth, Kathy K. Griendling, Bernard P. Lassegue, Rebecca S. Arnold, Guangie Cheng
-
Patent number: 7029673Abstract: The present invention relates to nucleotides encoding for the production of novel regulatory proteins for Nox enzymes involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these nucleotides, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these nucleotides and proteins, and methods to determine the activity of drugs to affect the biological activity of the regulatory proteins of the present invention.Type: GrantFiled: July 16, 2003Date of Patent: April 18, 2006Assignee: Emory UniversityInventors: J. David Lambeth, Guangjie Cheng
-
Patent number: 6846672Abstract: The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: November 15, 2001Date of Patent: January 25, 2005Assignee: Emory UniversityInventors: J. David Lambeth, Guangjie Cheng
-
Publication number: 20040253681Abstract: The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: ApplicationFiled: May 20, 2004Publication date: December 16, 2004Inventors: J. David Lambeth, Guangjie Cheng
-
Publication number: 20040093628Abstract: The present invention provides a transgenic non-human animal, in particular a transgenic mouse encoding the NOX and Duox family of proteins, which generate reactive oxygen intermediates (ROI). The present invention additionally comprises cells and cell lines containing transgenes encoding for members of the NOX and Duox family of proteins. The present invention further comprises methods and compositions for evaluating regulators of abnormal cell growth and in the development of compounds that effect ROI expression.Type: ApplicationFiled: July 14, 2003Publication date: May 13, 2004Inventors: J. David Lambeth, Guangjie Cheng, James McCoy
-
Publication number: 20040091466Abstract: The present invention relates to nucleotides encoding for the production of novel regulatory proteins for Nox enzymes involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these nucleotides, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these nucleotides and proteins, and methods to determine the activity of drugs to affect the biological activity of the regulatory proteins of the present invention.Type: ApplicationFiled: July 16, 2003Publication date: May 13, 2004Inventors: J. David Lambeth, Guangjie Cheng
-
Patent number: 6620603Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: GrantFiled: November 10, 1999Date of Patent: September 16, 2003Assignee: Emory UniversityInventors: J. David Lambeth, Kathy K. Griendling, Bernard P. Lassegue, Rebecca S. Arnold, Guangjie Cheng
-
Publication number: 20030166198Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: ApplicationFiled: December 13, 2002Publication date: September 4, 2003Inventors: J. David Lambeth, Kathy K. Griendling, Bernard P. Lassegue, Rebecca S. Arnold, Guangjie Cheng
-
Publication number: 20030157678Abstract: The present invention relates to new genes encoding for the production of novel proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: ApplicationFiled: December 13, 2002Publication date: August 21, 2003Inventors: Kathy K. Griendling, Bernard P. Lassegue, J. David Lambeth, Rebecca S. Arnold, Guangjie Cheng
-
Publication number: 20020176852Abstract: The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.Type: ApplicationFiled: November 15, 2001Publication date: November 28, 2002Inventors: J. David Lambeth, Guangjie Cheng